Rare cases of COVID returning pose questions for Pfizer pill
May 10, 2022 at 09:42 AM EDT
Pfizer's new OVID-19 pill has now come under scrutiny as a small number of patients relapsed after taking the drug.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |